Pieris Pharmaceuticals, Inc. (PIRS)

Pieris Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	11	18	77	272	140	199
Market Cap Growth	-75.08%	-76.75%	-71.59%	94.67%	-29.69%	38.17%
Enterprise Value	-8	-8	31	168	85	110
PE Ratio	-	-0.73	-2.33	-5.96	-3.76	-7.03
PS Ratio	0.28	0.42	2.99	8.67	4.77	4.30
PB Ratio	0.52	0.67	2.77	5.37	4.51	3.88
P/FCF Ratio	-0.36	-0.33	-1.27	-31.64	-2.88	-3.62
P/OCF Ratio	-0.36	-0.33	-1.29	-35.56	-3.05	-3.79
EV/Sales Ratio	-0.02	-0.20	1.21	5.36	2.91	2.38
EV/EBITDA Ratio	0.06	0.37	-1.03	-3.88	-2.44	-4.52
EV/EBIT Ratio	0.06	0.34	-0.94	-3.68	-2.30	-4.33
EV/FCF Ratio	0.02	0.16	-0.51	-19.57	-1.76	-2.01
Debt / Equity Ratio	-	-	0.47	0.27	0.51	0.30
Debt / EBITDA Ratio	-	-	-0.43	-0.32	-0.46	-0.63
Debt / FCF Ratio	-	-	-0.21	-1.61	-0.33	-0.28
Quick Ratio	3.09	2.45	1.79	2.39	3.26	4.11
Current Ratio	3.92	3.24	2.01	2.52	3.42	4.26
Asset Turnover	0.76	0.64	0.23	0.21	0.25	0.36
Return on Equity (ROE)	-54.30%	-86.70%	-82.40%	-96.50%	-87.00%	-93.10%
Return on Assets (ROA)	-30.20%	-36.70%	-29.80%	-31.10%	-32.20%	-21.80%
Return on Capital (ROIC)	-89.00%	-111.20%	-105.95%	-80.24%	-72.24%	-40.63%
Earnings Yield	-143.64%	-136.42%	-43.00%	-16.79%	-26.61%	-14.22%
FCF Yield	-441.40%	-300.09%	-78.79%	-3.16%	-34.75%	-27.60%
Buyback Yield / Dilution	-32.87%	-21.43%	-14.91%	-18.48%	-7.62%	4.63%
Total Shareholder Return	-32.87%	-21.43%	-14.91%	-18.48%	-7.62%	4.63%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).